Decisions of the Unified Patent Court recorded under "The Hague (NL) Local Division" in UPC Litigation Watch, the case law database maintained by Dhenne Avocats.
147 decisions recorded
By order of 15 September 2026 (UPC_CFI_1830/2026), the judge-rapporteur of The Hague Local Division dismissed two applications by Vertex Pharmaceuticals and Lonza Netherlands in ToolGen's infringement action based on EP 4 397 760 (genome editing using guide RNA and Cas protein), directed…
By order of 11 September 2026, the judge-rapporteur of The Hague Local Division defers Moderna’s preliminary objection on international jurisdiction to the main proceedings, dismisses its Rule 361 request and provisionally grants confidentiality protection limited to the representatives of CureVac Manufacturing GmbH.
By order of 11 September 2026, the panel of the Hague Local Division hearing GlaxoSmithKline Biologicals SA v Moderna (EP 2 590 626) revoked, after the oral hearing of 1 September 2026, the judge-rapporteur's order excluding GSK's new cryo-TEM imaging reports as…
The Hague Local Division allows Telefonaktiebolaget LM Ericsson (publ) to withdraw its three infringement actions against Shenzhen Transsion Holdings Co. Ltd. and nine other defendants on EP 2 712 236, EP 3 836 631 and EP 3 245 744, following a settlement…
The Hague Local Division allows the withdrawal, following a settlement, of the infringement action brought by Genevant Sciences GmbH and Arbutus Biopharma Corporation against Moderna, Inc.
In an order of 21 August 2026 issued in the joined files UPC_CFI_620/2025, UPC_CFI_1509/2025 and UPC_CFI_1511/2025, the judge-rapporteur of The Hague Local Division prepared the oral hearing of 3 September 2026 in the dispute between GlaxoSmithKline Biologicals SA and the Pfizer and…
In an order of 8 July 2026 issued in the joined proceedings UPC-CFI-0001536/2025, UPC-CFI-0000982/2026 and UPC-CFI-0001168/2026 (EP 3 079 153), The Hague Local Division dismissed the application for panel review brought by Dolby International AB and the intervener Vectis IP Ltd.
In an order of 29 July 2026 issued in the infringement action UPC_CFI_565/2024 (and proceedings UPC-CFI-0002246/2025) concerning EP 2 337 403 and EP 3 944 587, the judge-rapporteur of The Hague Local Division ruled on the confidentiality club in Koninklijke KPN v…
In an order of 13 August 2026 (UPC_CFI_1048/2025), the Hague Local Division declares inadmissible BTL Medizintechnik GmbH's request for reimbursement of 60% of the court fees following withdrawal of its infringement action against Lexter Microelectronic Engineering Systems S.L.
By decision of 10 August 2026, given in the infringement action (UPC_CFI_251/2025) and the joined counterclaim for revocation (UPC_CFI_769/2025), The Hague Local Division revokes Maxell, Ltd.’s EP 2 061 230 in its entirety and accordingly dismisses the action against four Samsung companies,…
By order of 10 August 2026 (UPC_CFI_619/2025, UPC_CFI_1526/2025 and UPC_CFI_2033/2025), The Hague Local Division deals, in the dispute between GlaxoSmithKline Biologicals SA and thirteen Moderna group companies, with the consequences of EPO decisions on two divisional patents stemming from the same application.
By order of 10 August 2026 (UPC_CFI_621/2025, UPC_CFI_1707/2025 and UPC_CFI_1708/2025), The Hague Local Division deals, in the dispute between GlaxoSmithKline Biologicals SA and companies of the Pfizer and BioNTech groups, with the consequences of EPO decisions on two divisional patents stemming from…
In a procedural order of 28 July 2026 (UPC_CFI_1540/2026), the judge-rapporteur of The Hague Local Division extends, for all defendants (Eppen Netherlands, three Eppen companies based in China and Oostvogels Logistics), the deadline for the statement of defence to six weeks after…
By order of 1 July 2026, the judge-rapporteur of The Hague Local Division dismisses CureVac Manufacturing GmbH’s Rule 190 RoP application for Moderna to produce extracts from its CTD dossier and technical data sheets on an RNA manufacturing process, and confirms the…
In an order of 22 June 2026, following a hearing on 9 June 2026 (UPC_CFI_1103/2026), the single judge of The Hague Local Division, on WEPA Nederland's request for review (Rule 197.3 RoP), confirms the ex parte order of 17 April 2026 that…
In the action for infringement of EP 2 590 626 brought by GlaxoSmithKline Biologicals SA against thirty Pfizer and BioNTech group companies (UPC_CFI_620/2025) and the joined counterclaims for revocation (UPC_CFI_1509/2025 and UPC_CFI_1511/2025), the judge-rapporteur of The Hague Local Division prepares the oral…
In proceedings UPC_CFI_1568/2025, UPC_CFI_1791/2025 and UPC_CFI_1793/2025 brought by Telefonaktiebolaget LM Ericsson (publ) against Shenzhen Transsion Holdings Co.
In the joined proceedings UPC_CFI_616/2025 (infringement) and UPC_CFI_1439/2025 (counterclaim for revocation) between GlaxoSmithKline Biologicals SA and Moderna Netherlands B.V.